QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Silverchair Science & Communications, LLC
ClinicalTrials.gov Identifier:
NCT01065493
First received: February 8, 2010
Last updated: May 1, 2013
Last verified: May 2013
  Purpose

QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.


Condition Intervention Phase
Smoking
Tobacco Use Disorder
Other: QuitAdvisorMD Software Algorithm
Behavioral: Standard Smoking Cessation Counseling
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

Resource links provided by NLM:


Further study details as provided by Silverchair Science & Communications, LLC:

Primary Outcome Measures:
  • The goal of the evaluation is to assess the ability of QuitAdvisorMD to influence smoking cessation as measured by the primary outcome of the increase in physician initiated smoking cessation counseling. [ Time Frame: 12 Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary outcomes will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts. [ Time Frame: 12 Months ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Software Assisted Lifestyle Counseling Other: QuitAdvisorMD Software Algorithm
QuitAdvisorMD, a set of brief clinical assessments, counseling scripts and intervention instruments for smoking cessation in primary care settings
Active Comparator: Lifestyle Counseling
Status quo smoking cessation counseling.
Behavioral: Standard Smoking Cessation Counseling
Standard Smoking Cessation Counseling

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits.

Exclusion Criteria:

  • Lack of appropriate computing device
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01065493

Locations
United States, Virginia
University of Virginia Health System
Charlottesville, Virginia, United States, 22908
Sponsors and Collaborators
Silverchair Science & Communications, LLC
Investigators
Principal Investigator: George Reynolds, BA Silverchair, Inc
Principal Investigator: Scott Strayer, MD University of Virginia Health System
  More Information

No publications provided

Responsible Party: Silverchair Science & Communications, LLC
ClinicalTrials.gov Identifier: NCT01065493     History of Changes
Other Study ID Numbers: R44 DA026682, R44DA026682
Study First Received: February 8, 2010
Last Updated: May 1, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 14, 2014